Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq

HONG KONG, Nov 13, 2022 – (ACN Newswire via SEAPRWire.com) – On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited (“Atour”) was officially listed on the Nasdaq Stock Exchange in the United States. It has priced its initial public offering of 4,750,000 American Depositary Shares (“ADSs”) at US$11.0 […]

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

HONG KONG, Nov 10, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as “PureFDA”) announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. This round of funds […]

Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round

HONG KONG, Nov 1, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. This round of financing will facilitate ClinBrain to continuously deepen its expertise in the field of healthcare big data, explore the deep […]

Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round

HONG KONG, Nov 1, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Easy-Flow (“Easy-Flow”) recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow’s peripheral intervention pipeline. Data shows that there are a large number of patients […]

Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round

HONG KONG, Oct 20, 2022 – (ACN Newswire via SEAPRWire.com) – VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as “VectorBuilder”), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. The proceeds will facilitate VectorBuilder in continuously promoting the upgrading and capacity expansion […]

The Next Vision Capital Announces an Investment from IDG Capital Blockchain

Hanoi, Vietnam, October 17, 2022 – (SEAPRWire) – Recently, the Next Vision Capital, a digital financial platform offering packages to SMEs, is proud to announce an Investment from IDG Capital Blockchain (IDGCB). IDG Capital Blockchain currently manages 40 million dollars and has been investing in over 30 companies under various sectors. Having found the potential of Next Vision Capital (NVC) in […]

Indonesia to offer 80/160-year building (HGB) permits in IKN Nusantara to incentivise investment

JAKARTA, Oct 14, 2022 – (ACN Newswire via SEAPRWire.com) – Indonesia’s Ministry of Agrarian Affairs and Spatial Planning/National Land Agency (ATR/BPN) is offering building use permits (HGBs) of up to 80 years, extendable to 160 years, as an incentive for investors to join in the construction of the Indonesian new capital (IKN) Nusantara, to be […]

AIM Vaccine, a Major Player in the Chinese Vaccine Industry Successfully Listed on the Main Board of SEHK

HONG KONG, Oct 6, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), was successfully listed and commenced trading on the […]

My Platform Joint Venture Awarded the Winner’s Prize in the 2022 Hong Kong-Macau-Taiwan Innovation and Entrepreneurship Competition

HONG KONG, Sep 29, 2022 – (ACN Newswire via SEAPRWire.com) – My Platform, the MedTech venture in which Black Spade Capital Limited (“Black Spade Capital”) invested, has just announced that its PRC joint venture My Platform Information Technology (Guangzhou) Limited (“My Platform MedTech”) was awarded the Winner’s Prize in the 2022 Hong Kong-Macau-Taiwan Innovation and […]

GalaxySpace Completes a New Financing Round with Legend Capital Re-upped

HONG KONG, Sep 25, 2022 – (ACN Newswire via SEAPRWire.com) – GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. As an existing shareholder, Legend Capital continued to support the company by following up on this financing round. Legend Capital first invested in GalaxySpace […]

Leadrive Technology Completes Series C Financing, Legend Capital Re-upped

HONG KONG, Sep 25, 2022 – (ACN Newswire via SEAPRWire.com) – Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing. This round of financing will be […]

TR Capital Positions Firm to Capture Tremendous Growth Opportunity in Southeast Asia with New Singapore Office

SINGAPORE, Sep 16, 2022 – (ACN Newswire via SEAPRWire.com) – TR Capital, the leading Asian secondary private equity firm, today announced the opening of its fifth office in the APAC region, and the firm’s Southeast Asia Headquarters, in Singapore. Paul Robine, Founder and CEO of TR Capital, said, “We see huge potential in the secondary […]

Leading VC Firm, Black3Lab Capital Announces Investment in Ripe Web 3.0 Sectors

New York, NY, September 02, 2022 – (SEAPRWire) – Black3Lab Capital, a venture capital firm built to empower web 3.0 companies with potential for global mass adoption, has announced investments in ripe web 3.0 sectors. Black3Lab’s proposed $50 to $100 million fund will focus on building a genuinely feasible economy of web 3.0-fueled products and services for the […]

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

BRISBANE, AUS, Aug 30, 2022 – (ACN Newswire via SEAPRWire.com) – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm. With more than two decades of experience, AcuraBio is a globally focussed organization bringing innovative therapeutics […]

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY

HONG KONG, Aug 19, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Applied Protein Technology Co., Ltd. (“APTBIO”), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. The proceeds from this round […]

Elite Partners continues acquisition spree with the purchase of a warehouse in Poland

Singapore, Aug 16, 2022 – (ACN Newswire via SEAPRWire.com) – Elite Partners Capital has completed an off-market acquisition of a warehouse in Radomsko, Poland for close to EUR30 million. This marks the firm’s third purchase within a span of six weeks, after announcing acquisitions in UK and Netherlands. The asset is well-located in Central Poland, […]

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

HONG KONG, Aug 15, 2022 – (ACN Newswire via SEAPRWire.com) – On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. R&G Pharmastudies publicly issued 15,000,000 shares at a price of RMB78.88 per share, and the […]